Predictors and Outcomes of Ad Hoc Versus Non-Ad Hoc Percutaneous Coronary Interventions  by Hannan, Edward L. et al.
P
N
E
D
S
A
B
O
v
B
b
o
M
S
2
t
R
o
l
h
9
t
0
C
f
I
F
‡
N
r
a
D
O
M
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 2 , N O . 4 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 9 . 0 1 . 0 0 6redictors and Outcomes of Ad Hoc Versus
on-Ad Hoc Percutaneous Coronary Interventions
dward L. Hannan, PHD,* Zaza Samadashvili, MD,* Gary Walford, MD,†
avid R. Holmes, MD,‡ Alice Jacobs, MD,§ Samin Sharma, MD, Stanley Katz, MD,¶
pencer B. King III, MD#
lbany, Syracuse, New York, and Manhasset, New York; Rochester, Minnesota;
oston, Massachusetts; and Atlanta, Georgia
bjectives Our aim was to compare longer-term outcomes for ad hoc percutaneous coronary inter-
ention (PCI) and non-ad hoc PCI.
ackground Ad hoc PCIs, whereby PCI is performed immediately after cardiac catheterization, has
ecome the most common way of performing PCI. However, no studies have compared longer-term
utcomes for ad hoc and non-ad hoc PCIs.
ethods A total of 46,565 New York State patients who underwent PCI in nonfederal New York
tate hospitals between January 1, 2003 and June 30, 2005 were followed through December 31,
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ower 36-month mortality (adjusted hazard ratio [HR]: 0.76, 95% CI: 0.69 to 0.85, p  0.0001). Ad
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351n recent years, there has been an enormous increase in the
umber of percutaneous coronary interventions (PCIs) per-
ormed in the U.S. For example, the number has risen from
lightly more than 400,000 procedures in 2000 to 1,265,000
n 2005 (1).
In conjunction with this increase, there has been a
endency to improve efficiency by performing PCIs imme-
iately after cardiac catheterization (ad hoc PCIs). Potential
dvantages of such an approach are a reduction in resources
ue to a single catheterization laboratory visit and a poten-
ially shorter length of stay, greater patient satisfaction
ecause performing both procedures together is simpler and
reates less anxiety, a lower risk of contrast nephropathy
especially in patients with baseline renal insufficiency), and
asier access site management (2,3). Potential disadvantages
nclude an abbreviated informed consent process (particu-
arly for interventions for which there is an alternative
ntervention), the need for immediate decision making
egarding the appropriateness of the procedure, and diffi-
ulties obtaining surgical backup (particularly on nights and
eekends) (3).
Several studies have examined the frequency with which
d hoc PCI is performed (3–9). However, many of these
tudies are relatively old, and the outcomes investigated
ere short-term outcomes. This study reports on the use of
d hoc procedures for PCI in all of New York State in a
ecent time period, and compares short- and medium-term
utcomes for ad hoc versus non-ad hoc PCIs.
ethods
ata. The database used in the study is New York’s
ercutaneous Coronary Interventions Reporting System
PCIRS), a mandatory registry in New York that was
nitially developed in 1992 that contains detailed informa-
ion for each patient undergoing PCI in the state on
emographics; pre-procedural risk factors; peri-procedural
omplications; types of devices used; lesions diseased; dates
f admission, discharge, and procedure; discharge disposi-
ion and destination; and hospital and operator identifiers.
he PCIRS contains information on diseased and at-
empted lesions, including regions of the heart, whether or
ot a lesion was attempted, and pre- and post-procedural
tenosis. The data are collected by hospital catheterization
aboratories, entered on paper forms, and then submitted to
he New York State Department of Health on diskettes or
hrough a web-based submission process. The data are
hecked for accuracy and completeness by matching to
dministrative data and by extensive auditing of medical
ecords by the New York State Department of Health’s
tilization review agent.
The PCIRS data were matched to New York’s vital
tatistics data so that patients could be followed after
ischarge for evidence of subsequent death. Data from New Cork’s Cardiac Surgery Reporting System were used along
ith PCIRS data to identify repeat revascularizations after
ischarge through December 31, 2005.
atients. Patients in the study were derived from the
05,390 patients who underwent PCI in nonfederal New
ork State hospitals between January 1, 2003 and June 30,
005. Exclusions were 3,617 patients with left main disease;
5,293 with acute myocardial infarction within 24 h, shock,
emodynamic instability, or coded as an emergency priority
atient; 34,779 with a previous PCI or coronary artery
ypass graft (CABG) surgery; 4,049 who were not New
ork residents; 10,599 whose catheterization hospital was
ot known or different from their PCI hospital; and 7,340
ith a missing ejection fraction. The remaining 46,565
atients were included in the study.
Patients with a diagnostic catheterization performed in a
on-PCI hospital were excluded because the fact that they
ere not candidates for ad hoc PCI introduces a selection
ias. Patients with previous re-
ascularization were excluded
ecause their adverse outcomes
ould have been related to the
arlier revascularization. The
tudy was limited to New York
esidents because the New York
ital Statistics Death File only
pplies to residents of the state.
ll patients in the study were
ollowed through December 31,
005 for evidence of death or
ubsequent revascularization in
ew York.
nd points. End points in the
tudy were 36-month mortality,
ubsequent revascularization
ith and without the exclusion
f staged PCIs occurring within 30 days of the index
rocedure, subsequent target vessel revascularization with
CI or CABG surgery, and repeat target vessel PCI. These
dverse outcomes were risk-adjusted to account for differ-
nces in baseline risk of ad hoc and non-ad hoc PCI patients
s described in the following text.
tatistical analysis. Differences in baseline characteristics
etween ad hoc and non-ad hoc PCI patients (e.g., demo-
raphics, comorbidities, left ventricular function, vessels
iseased, symptoms) were examined using Fisher exact and
hi-square tests. To test for risk-adjusted differences in the
dverse outcomes between ad hoc and non-ad hoc patients,
roportional hazards models with a robust covariance matrix
hat accounts for correlation of survival times for individuals
ithin a hospital or operator cluster (10) were developed for
ach adverse outcome measure after having confirmed that
he proportional hazards assumption was justified (11).
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
CCS  Canadian
Cardiovascular Society
CI  confidence interval
HR  hazards ratio
LAD  left anterior
descending coronary artery
OR  odds ratio
PCI  percutaneous
coronary intervention
PCIRS  Percutaneous
Coronary Interventions
Reporting Systemandidate independent variables included the patient risk
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352actors available in PCIRS (demographics, left ventricular
unction, myocardial infarction more than 1 day before the
rocedure, and numerous comorbidities). Variables that
ere statistically significant in a stepwise analysis were
etained in each model.
Type of delivery (ad hoc, non-ad hoc) was used in each
odel as the study independent variable with ad hoc treated
s the indicator variable, and the ad hoc/non-ad hoc
djusted hazards ratios (HRs) were obtained by exponenti-
ting the coefficient of that variable. To test for selection
ias, a propensity model was developed (12,13). The risk
actors in Table 1 were used as independent variables in a
ogistic regression model with a binary dependent variable
epresenting ad hoc/non-ad hoc PCI. The propensity score
as subdivided into quintiles, and 36-month HRs for ad
oc/non-ad hoc PCI were examined across quintiles for
ortality, subsequent revascularization, and repeat target
essel PCI to determine if there was any trend or major
ifference based on whether the PCI was staged or ad hoc.
ll tests were 2-sided and conducted at the 0.05 level, and
ll analyses were conducted in SAS 9.1 (SAS Inc., Cary,
orth Carolina).
esults
total of 38,431 patients (82.5%) received ad hoc PCIs and
,134 patients (17.5%) received non-ad hoc PCIs. The
ercentage of PCI patients undergoing ad hoc PCI in-
reased in every 6-month period from a low of 78.8% to a
igh of 85.4%. The variation across hospitals in the per-
entage of patients who underwent ad hoc PCIs was from
5% to 97%. The median follow-up time was 19.45 months,
nd 17.2% of the patients had a follow-up time of at least 30
onths.
Table 1 presents the prevalences of patient characteristics
or ad hoc and non-ad hoc procedures. As indicated,
atients receiving ad hoc procedures were younger, more
ikely to be men and Hispanic, had higher ejection fractions,
ere less likely to have suffered a previous myocardial
nfarction, more likely to have Canadian Cardiovascular
ociety (CCS) class IV, more likely to undergo stenting
ith drug-eluting stents, and less likely to have any of
umerous comorbidities.
With regard to in-hospital mortality, ad hoc patients had
ignificantly lower unadjusted mortality (0.25% vs. 0.45%,
nadjusted ad hoc/non-ad hoc odds ratio [OR]: 0.52, 95%
onfidence interval [CI]: 0.37 to 0.73). However, after
djustment the difference was not significant (adjusted OR:
.82, 95% CI: 0.55 to 1.22, data not shown). Ad hoc PCI
atients experienced lower rates of renal failure (0.07% vs.
.14%) and myocardial infarction (0.85% vs. 0.95%) than
on-ad hoc PCI patients. There was no difference in
ortality between centers with high and low rates of PCIfter adjustment for other factors. iTable 2 presents risk-adjusted HRs (ad hoc/non-ad hoc)
or 5 adverse events (mortality, subsequent revascularization,
ubsequent revascularization excluding staged PCIs occur-
ing within 1 month of the index procedure, subsequent
evascularization of the target vessel with PCI or CABG,
nd repeat target vessel PCI) at 36 months. As indicated, ad
oc PCI patients had significantly lower mortality (adjusted
R: 0.76, 95% CI: 0.69 to 0.85, p  0.0001). This
ifference remained significant after adjusting for hospital
olume. Ad hoc patients had a significantly higher subse-
uent revascularization rate (adjusted HR: 1.11, 95% CI:
.01 to 1.21, p  0.03). After excluding subsequent PCIs
hat occurred within 30 days of the index PCI in another
essel, there was no longer a significant difference in
ubsequent revascularization (adjusted HR: 1.03, 95% CI:
.95 to 1.12, p  0.43) (Table 2). There were no significant
ifferences in subsequent target vessel revascularization
adjusted HR: 0.95, 95% CI: 0.88 to 1.03, p  0.23) or in
epeat target vessel PCI (adjusted HR: 0.97, 95% CI: 0.89
o 1.07, p  0.52).
As indicated in Table 3, the mortality advantage with ad
oc PCI for women (adjusted HR: 0.78, 95% CI: 0.66 to
.91, p  0.002) and patients with multivessel disease
adjusted HR: 0.77, 95% CI: 0.68 to 0.87, p 0.0001) were
ll about the same and nearly identical to the adjusted HR
f 0.76 for all patients presented in Table 2. The adjusted
Rs for patients with congestive heart failure (adjusted HR:
.82, 95% CI: 0.69 to 0.97, p  0.02), CCS class IV
adjusted HR: 0.80, 95% CI: 0.66 to 0.97, p  0.02), and
atients of age 75 and older (adjusted HR: 0.80, 95% CI:
.70 to 0.92, p  0.002) were somewhat higher but still
ignificant.
Significant predictors of ad hoc versus non-ad hoc pro-
edure in the propensity analysis were age, sex, race,
thnicity, body surface area, number of vessels diseased with
r without proximal LAD, ejection fraction, angina class
V, history of myocardial infarction before procedure, cere-
rovascular disease, peripheral arterial disease, congestive
eart failure, diabetes, renal failure with no dialysis, organ
ransplant, and type of stent inserted. The results of the
ropensity analyses demonstrated that adjusted HRs for
uintiles for each of the outcome measures were quite close
o the HRs for all patients for that outcome measure. For
he measures with significant differences (mortality and
ubsequent revascularization), only 2 of 10 quintile HRs
ere in the opposite direction of the HR for all patients, and
hose favored ad hoc PCI when it was used the least. In
eneral, there was no trend toward more favorable HRs for
d hoc PCI when it was predicted to be used the most. The
statistic for the propensity model was 0.61, a relatively
ow value that indicates that, despite the number of signif-
cant variables in the model, there was a low ability to
dentify factors that predicted the use of ad hoc PCI.
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353Table 1. Risk Factors for Ad Hoc and Non-Ad Hoc PCIs in New York: January 1, 2003 to June 30, 2005
Risk Factor
% in Population
(n  46,565)
% With Ad Hoc PCI
(n  38,431)
% With Non-Ad Hoc PCI
(n  8,134) p Value
Total 100 82.5 17.5
Demographic characteristics
Age (yrs) 0.0001
59 or less 35.43 36.60 29.89
60 to 69 28.35 28.63 27.01
70 to 79 25.16 24.41 28.72
80 or more 11.06 10.36 14.38
Female gender 36.00 35.38 38.94 0.0001
Race 0.0001
White 83.41 83.00 85.35
Black 9.82 9.73 10.24
Other 6.78 7.28 4.41
Hispanic ethnicity 8.50 8.76 7.27 0.0001
Body surface area (mean  SD) — 2.01 2.02 0.15
Priority of intervention 0.49
Elective 51.48 51.55 51.13
Urgent 48.52 48.45 48.87
Cardiac risk factors
Number of vessels diseased 0.0001
1 without proximal LAD 45.06 46.22 39.55
1 with proximal LAD 11.48 11.73 10.29
2 without proximal LAD 23.96 23.64 25.47
2 with proximal LAD 7.95 7.73 8.99
3 11.56 10.68 15.70
Lesion type
Chronic total occlusion 3.12 3.03 3.59 0.008
Ejection fraction (%) 0.0001
19 or less 0.63 0.50 1.27
20 to 29 2.59 2.27 4.14
30 to 39 5.62 5.33 6.96
40 to 49 13.48 13.50 13.34
50 or more 77.68 78.40 74.29
Previous MI (days) 0.0001
1 to 7 18.81 19.51 15.47
8 to 14 1.53 1.04 3.84
15 to 20 0.33 0.22 0.87
21 and older 9.51 9.16 11.18
None 69.82 70.07 68.65
CCS class 0.0001
I to III 73.41 72.65 76.97
IV 24.30 25.03 20.81
None of above category 2.30 2.32 2.21
Type of PCI
Stent placement 0.002
Yes 96.43 96.55 95.86
Type of device used 0.0001
DES 74.65 75.59 70.22
BMS without DES 19.57 18.85 23.01
Other 5.77 5.57 6.76
Comorbidities
Cerebrovascular disease 6.65 6.20 8.78 0.0001
Peripheral vascular disease 5.62 5.14 7.88 0.0001
CHF history 0.0001
None 91.96 92.81 87.96
Before this admission 5.83 5.17 8.93
This admission 2.21 2.02 3.11
Malignant ventricular arrhythmia 0.39 0.35 0.58 0.003
COPD 6.81 6.67 7.44 0.01
Diabetes 27.89 27.17 31.26 0.0001
Renal dialysis 1.66 1.49 2.50 0.0001
Creatinine 2.5 mg 2.24 1.94 3.69 0.0001
Organ transplant 0.23 0.19 0.38 0.001
BMSbare-metal stent(s); CCSCanadianCardiovascular Society; CHF congestiveheart failure; COPD chronicobstructivepulmonarydisease;DESdrug-eluting stent(s); LAD left anterior descendingcoronary artery; MImyocardial infarction; PCI percutaneous coronary intervention.
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354iscussion
d hoc PCIs (PCIs performed in the same catheterization
aboratory visit as the diagnostic catheterization) have be-
ome commonplace in recent years. A few earlier studies
ave examined predictors and outcomes of ad hoc PCI. In
study using data from the American College of Cardiol-
gy’s National Cardiovascular Data Registry from 2001 to
003, Krone et al. (3) found that 60.6% of patients under-
ent ad hoc PCI, and there was no difference between ad
oc and non-ad hoc PCI with respect to in-hospital
ortality, renal failure, and vascular complications. Fewer
d hoc patients (58.6% vs. 63.0%) tended to be high risk (3).
In a study using 1995 to 1998 data from New York’s
ngioplasty registry, Goldstein et al. (5) found that ad hoc
atients were less likely to have each of several different
Table 2. Adjusted HRs (Ad Hoc vs. Non-Ad Hoc) and 95% CIs for Mortality
Non-TVR Within 30 Days of Index PCI, and TVR: New York, January 1, 200
Outcomes
Non-Ad Hoc PCI (n  8,134)
Mean Time
of Follow-Up
(Months)
Number
of Events
Mortality 20.7 630
Subsequent revascularization 17.3 1,678
Subsequent revascularization
(excludes staged PCIs)
18.6 1,395
Subsequent TVR (PCI or CABG) 18.7 978
Repeat target vessel PCI 19.2 728
Adjusted for age, sex, race, ethnicity, body surface area, number of vessels diseasedwith or without
procedure, cerebrovascular disease, peripheral arterial disease,malignant ventricular arrhythmia, ch
transplant, and type of stent inserted.
CABG coronary artery bypass grafting; CI confidence interval; HR hazard ratio; PCI perc
Table 3. Adjusted HRs (Ad Hoc vs. Non-Ad Hoc) and 95% CIs for 36 Month
January 1, 2003 to June 30, 2005
Patient Group Timing of PCI
Number
of Cases
Female gender Non-ad hoc 3,167
Ad hoc 13,595
Age 75 yrs Non-ad hoc 2,366
Ad hoc 8,348
Multivessel disease Non-ad hoc 4,080
Ad hoc 16,158
Congestive heart failure Non-ad hoc 979
Ad hoc 3,355
CCS class IV Non-ad hoc 1,693
Ad hoc 9,620
Adjusted for age, sex, race, ethnicity, body surface area, number of vessels diseasedwith or without
procedure, cerebrovascular disease, peripheral arterial disease,malignant ventricular arrhythmia, ch
transplant, and type of stent inserted.Abbreviations as in Table 2.omorbidities and that there was no difference in in-hospital
ortality (ad hoc/non-ad hoc OR: 1.14, p 0.38), but that
d hoc patients had higher mortality if they had congestive
eart failure (OR: 1.59, p  0.04) and CCS class IV (OR:
.64, p  0.04) (5). Feldman et al. (6) used 2000 to 2001
ata from the same registry to demonstrate that there were
o differences between ad hoc and staged PCI patients with
espect to in-hospital mortality, major adverse cardiac
vents, or renal failure, but that staged patients trended
oward a higher rate of site access site injury (adjusted OR:
.34, 95% CI: 0.99 to 1.81). High-risk patients did not have
ifferent in-hospital outcomes (6).
Our study is an extension of earlier studies in 2 major
espects. First, it spans a time period that is entirely in the
ra of drug-eluting stents. Second, and more importantly,
equent Revascularization, Subsequent Revascularization Excluding
une 30, 2005
Ad Hoc PCI (n  38,431)
Adjusted HR for
Ad Hoc Relative to
Non-Ad Hoc PCI p Value
ean Time
Follow-Up
Months)
Number
of Events
19.6 1,630 0.76 (0.69–0.85) 0.0001
16.3 7,975 1.11 (1.01–1.21) 0.03
17.3 6,404 1.03 (0.95–1.12) 0.43
17.9 4,158 0.95 (0.88–1.03) 0.23
18.3 3,301 0.97 (0.89–1.07) 0.52
al left anterior descending coronary artery, ejection fraction, history of myocardial infarction before
structive pulmonary disease, diabetes, renal failurewithdialysis, renal failurewith nodialysis, organ
s coronary intervention; TVR target vessel revascularization.
ality in Selected Patient Subgroups, New York:
Mortality
Number
of Events Adjusted HR p Value
286 Reference
734 0.78 (0.66–0.91) 0.002
326 Reference
757 0.80 (0.70–0.92) 0.002
383 Reference
845 0.77 (0.68–0.87) 0.0001
212 Reference
443 0.82 (0.69–0.97) 0.02
163 Reference
509 0.80 (0.66–0.97) 0.02
al left anterior descending coronary artery, ejection fraction, history of myocardial infarction before
structive pulmonary disease, diabetes, renal failurewithdialysis, renal failurewith nodialysis, organ, Subs
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355his study compares longer-term out-of-hospital outcomes
or ad hoc and non-ad hoc PCI patients.
Our study demonstrates that of all patients undergoing
atheterization in hospitals approved to perform PCI in
ew York between 2003 and 2005 who underwent elective
CIs without having had previous revascularization, a total
f 83% received ad hoc PCIs. Consequently, it is important
o compare these patients’ relative risk-adjusted outcomes
ith those of other PCI patients who receive PCI at a later
ime than their catheterization visit (non-ad hoc patients).
urthermore, since in-hospital adverse event rates are so low
or elective patients in particular, it is also important to
ompare longer-term outcomes of ad hoc and non-ad hoc
CI patients. In particular, it is of interest to determine
hether certain patient characteristics are associated with
ignificantly better or significantly worse outcomes for ad
oc PCI patients compared with non-ad hoc patients.
Since ad hoc PCI patients undergo PCI after a short
ecision-making period without the aid of a multidisci-
linary clinical team, it is of interest to contrast the patient
haracteristics of ad hoc and non-ad hoc patients and to
xamine the indications for PCI among ad hoc patients.
Findings of our study were that there was a large variation
cross hospitals in New York with respect to the use of ad
oc PCI (35% to 97% among patients receiving their cardiac
atheterization in the same hospital). This variation was
maller than the variation found in an earlier study in New
ork (which was between 7% and 86%), and the overall
ercentage of ad hoc procedures rose from 62% in the earlier
995 to 1998 study to 83% in this 2003 to 2005 study (5).
Patients receiving ad hoc procedures were of lower risk on
verage (younger, with higher ejection fractions, less likely
o have suffered a previous myocardial infarction, and less
ikely to have important comorbidities). Other findings were
hat there was no difference in risk-adjusted in-hospital
ortality (adjusted ad hoc/non-ad hoc OR: 0.82, 95% CI:
.55 to 1.22). Ad hoc PCI patients had significantly lower
6-month mortality (adjusted HR: 0.76, 95% CI: 0.69 to
.85, p  0.0001). Ad hoc PCI patients had significantly
igher 36-month subsequent revascularization (adjusted
R: 1.11, 95% CI: 1.01 to 1.21, p  0.03). After excluding
ubsequent PCIs that occurred within 30 days of the index
CI in another vessel, the difference was no longer signif-
cant (adjusted HR: 1.03, 95% CI: 0.95 to 1.12, p  0.43).
here were no significant differences in subsequent target
essel revascularization (adjusted HR: 0.95, 95% CI: 0.88 to
.03, p 0.22) or in repeat target vessel PCI (adjusted HR:
.99, 95% CI: 0.91 to 1.08, p  0.88).
It is also notable that 2 subsets of patients (congestive
eart failure and CCS class IV) that had worse outcomes for
d hoc PCI in an earlier New York study (5) experienced
ignificantly better longer-term mortality in this study.
The lower mortality rate for ad hoc PCI could be a result
f any combination of decrease in vascular complications, iariations in anticoagulation regimens, the risk associated
ith a second catheterization procedure, or differences in
aseline risk not accounted for in our risk-adjustment
rocess because of selection bias caused by variables not
vailable in our database.
However, there are some concerns about the use of ad hoc
CI. As indicated in Table 1, 10.7% of the ad hoc PCI
atients had 3-vessel disease, and 7.7% and 11.7% had
-vessel left anterior descending coronary artery (LAD)
isease and 1-vessel LAD disease, respectively. Thus, a total
f 30.1% of ad hoc PCI patients were in categories that are
egarded as candidates for CABG surgery. Although a
igher percentage (35.0%) of non-ad hoc PCI patient were
n 1 of these 3 categories, and there are various reasons why
ABG surgery may have been contraindicated for these
atients, this is nevertheless a high percentage of patients
or whom either type of revascularization was seemingly an
ption given the most recent guidelines for CABG surgery
14).
There are a few limitations to the study. First, it is an
bservational study and is, therefore, subject to selection
ias of various types, which could bias the study in favor of
ither ad hoc or not ad hoc PCI. This includes variables not
resent in the databases, such as whether a patient was
ontraindicated for CABG surgery. Nevertheless, we risk-
djusted the outcomes to the extent possible and used
ropensity analyses to subdivide patients into groups based
n their tendency to undergo ad hoc PCI, and found no
arge difference in relative outcomes among the different
roups. However, in general, decisions to perform ad hoc
CI were made by individual operators, and their reasons
ere not contained in our database. Also, the C statistic for
he propensity analysis was low (0.61), and this may be
ndicative of missing predictors of ad hoc PCI in our
atabase.
Although our databases contained detailed information
n patient risk factors for short-term outcomes, we did not
ave access to all factors related to guidelines for the use of
CI and CABG surgery. Consequently we were unable to
recisely identify all patients indicated for each procedure.
hus, we were unable to identify all patients who were
andidates for CABG surgery although some were identi-
ed based on vessels diseased and LAD involvement.
urthermore, we were unable to identify patients who were
ot indicated for PCI because of limited coronary artery
isease, and to the extent that there was a higher percentage
f these patients in 1 of the 2 groups, this could have biased
he results because these patients should experience better
onger-term outcomes.
onclusions
e believe that this is the first study to explore differences
n longer-term outcomes based on whether patients under-
w
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356ent ad hoc PCI. We look forward to similar studies in
ther settings.
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